Company: DXPE
Filing Date: 2025-03-10
Form Type: 10-K
Source: 0001020710-25-000036
Chunk: 31

Company: DXP ENTERPRISES INC
Filing Date: 2025-03-10
Form: 10-K
Item: Item 7A
Chunk 31
---
 the original grant date value. The Company issues new shares of common stock, if available, to settle vested RSAs. At December 31, 2024, 370,962 shares were available for grant.Changes in RSAs for the twelve months ended December 31, 2024 are as follows: Number ofSharesWeighted AverageGrant PriceNon-vested at December 31, 2023304,437 $27.60 Granted127,860 $52.89 Forfeited(9,644)$26.96 Vested(120,253)$28.13 Non-vested at December 31, 2024302,400 $38.11 Changes in RSAs for the twelve months ended December 31, 2023 are as follows: Number ofSharesWeighted AverageGrant PriceNon-vested at December 31, 2022157,767 $28.64 Granted215,554 $27.36 Forfeited— $— Vested(68,884)$29.23 Non-vested at December 31, 2023304,437 $27.60 Changes in RSAs for the twelve months ended December 31, 2022 are as follows: Number ofSharesWeighted AverageGrant PriceNon-vested at December 31, 2021112,044 $31.72 Granted113,077 $27.48 Forfeited(8,785)$31.96 Vested(58,569)$31.79 Non-vested at December 31, 2022157,767 $28.64 

69

Compensation expense, associated with RSAs, recognized in the years ended December 31, 2024, December 31, 2023 and December 31, 2022 was $4.7 million, $3.1 million and $1.9 million, respectively. Related income tax benefits recognized in earnings in the years ended December 31, 2024, December 31, 2023 and December 31, 2022 were approximately $0.8 million, $0.8 million and $0.5 million, respectively. The aggregate grant-date fair value of vested shares for the years ended December 31, 2024, December 31, 2023 and December 31, 2022 was $3.4 million, $